| Schedule of Earnings Per Share, Basic and Diluted |
The following table sets forth the computation of basic and diluted net income (loss) per share attributable to common stockholders (in thousands, except share and per share amounts):
| | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended June 30, | | Six Months Ended June 30, | | 2025 | | 2024 | | 2025 | | 2024 | | Numerator: | | | | | | | | | Net income (loss) from continuing operations | $ | 2,683 | | | $ | (7,491) | | | $ | 3,043 | | | $ | (13,192) | | | Add: stock based compensation expense, net of tax | — | | | — | | | 43 | | | — | | | Add: (gain) loss on convertible note, net of tax | (99) | | | — | | | 750 | | | — | | | Net income (loss) attributable to common stockholders from continuing operations, dilutive | 2,584 | | | (7,491) | | | 3,836 | | | (13,192) | | | Net income (loss) from discontinued operations | 919 | | | (9,427) | | | 1,014 | | | (21,116) | | | | | | | | | | | Denominator: | | | | | | | | | Weighted-average common shares outstanding, basic | 2,592,878 | | | 1,174,385 | | | 2,229,573 | | | 1,169,319 | | | | | | | | | | | Add: 2024 convertible note and second tranche note on as-converted basis | 2,068,223 | | | — | | | 2,276,803 | | | — | | | Weighted-average shares outstanding, dilutive | 4,661,101 | | | 1,174,385 | | | 4,506,376 | | | 1,169,319 | |
|
| Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share |
The following securities were excluded due to their anti-dilution effect on net loss per share attributable to common stockholders recorded in each of the periods:
| | | | | | | | | | | | | As of June 30, | | 2025 | | 2024 | | Warrants to purchase common stock | 1,161,195 | | | 1,161,195 | | | Stock options outstanding | 17,857 | | | 80,928 | | | Restricted stock units with performance and market conditions | 10,964 | | | 11,864 | | | Total | 1,190,016 | | | 1,253,987 | |
|